We recently compiled a list of the Top 8 AI News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

Quest Diagnostics (NYSE:DGX) said on Wednesday that it expects first quarter revenue and EPS to take a hit from the weather ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

This was the stock's second consecutive day of losses.

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

This week, Quest Diagnostics made one of those deals. The diagnostics giant announced a new partnership with Google Cloud that aims to deliver new AI capabilities — including predictive ...

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research Report), ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate ...